Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Hair restoration surgery redistributes existing hair to achieve a natural look, with visible regrowth in 3-4 months and rare complications, mostly aesthetic.

Individualized assessment and meticulous planning are crucial for successful brow and upper eyelid surgery.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Hydroxychloroquine can help treat certain types of hair loss.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Topical finasteride helps regrow hair and reduce hair loss in men and women.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Both genetic and lifestyle factors significantly affect female hair loss.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

Minoxidil effectively treats female pattern hair loss.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.